Watch 5 Stocks: Express Inc. (NYSE:EXPR), NPS Pharmaceuticals (NASDAQ:NPSP), Nucor Corporation (NYSE:NUE), Advanced Emissions Solutions (NASDAQ:ADES), Tenet Healthcare Corp. (NYSE:THC)


Apparel retailer Express Inc (NYSE:EXPR) said it terminated talks to be bought by private equity firm Sycamore Partners, its largest shareholder. The company said talks ended due to the “unavailability of financing on commercially acceptable terms”. On Tuesday shares of Express Inc. (NYSE:EXPR) closed at $12.59. Company’s sales growth for last 5 years was 5.00% and EPS growth for next 5 years is recorded as 19.00%.

An investigation on behalf of investors, who currently hold shares of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), was announced concerning whether the takeover of NPS Pharmaceuticals, Inc. by Shire plc for $46.00 per share is unfair to NASDAQ:NPSP stockholders. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) in last trading activity increased 0.35% to close at $45.61. Company weekly performance is 0.57% while its quarterly performance stands at 74.35%. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is -0.20% away from its 52 week high.

Nucor Corporation (NYSE:NUE) fourth quarter earnings will release, on Tuesday, January 27, 2015, at 2 p.m. Eastern Time. On last trading day Nucor Corporation (NYSE:NUE) fell -0.74% to close at $44.09. Its volatility for the week is 2.35% while volatility for the month is 2.21%. NUE’s sales growth for past 5 years was -4.20% and its EPS growth for past 5 years was -24.00%. Nucor Corporation (NYSE:NUE) monthly performance is -10.22%.

The Shareholders Foundation announced on 6 January that an investigation on behalf of current long-term investors in shares of Advanced Emissions Solutions, Inc. (NASDAQ:ADES) shares was launched over potential breaches of fiduciary duties by certain officers and directors at Advanced Emissions Solutions. Advanced Emissions Solutions, Inc. (NASDAQ:ADES) has 14.39% insider ownership while its institutional ownership stands at 53.40%. In last trading activity company’s stock closed at $19.52.

Shares of Tenet Healthcare Corp (NYSE:THC) have been given a consensus recommendation of “Hold” by the nineteen analysts that are covering the company, Stock Ratings News reports. Ten analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $59.82.On last trading day Tenet Healthcare Corp. (NYSE:THC) fell -0.62% to close at $44.70. Its volatility for the week is 3.75% while volatility for the month is 3.40%. THC’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was -32.10%. Tenet Healthcare Corp. (NYSE:THC) monthly performance is -7.72%.


Leave a Reply

Your email address will not be published. Required fields are marked *